The purpose of this study is to see if combining silevertinib with temozolomide after surgery and radiotherapy helps treat newly diagnosed glioblastoma (GBM) b…

Glioblastoma (GBM)Newly Diagnosed GlioblastomaGBM+4 more

~Estimated

~$10 – $8,750

Black Diamond Therapeutics, Inc.NCT07326566

Phase 1

Dosimetry and Bio-distribution of 203Pb-RMX-VH-PIB in Newly Diagnosed or Recurrent Patients With Solid Tumors: A Phase I Exploratory Study

The goal of this Phase I clinical trial is to evaluate how the imaging drug 203Pb- RMX-VH-PIB distributes in the body and how much radiation different organs r…

Glioblastoma Multiforme (GBM)Pancreatic Ductal Adenocarcinoma (PDAC)

~Estimated

~$10 – $8,750

Radiomedix, Inc.NCT07733674

Phase 1

Phase I/II Study of Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed Glioblastoma (GBM)

The purpose of this study is to evaluate the safety and efficacy of administering the medication capecitabine along with temozolomide when you start your month…

Glioblastoma Multiforme (GBM)GlioblastomaGlioma of Brain+6 more

~Estimated

~$10 – $7,500

Northwell HealthNCT03213002